Stockreport

J&J Acquires Experimental Eczema Drug in $1.25 Billion Cash Deal [BNN Bloomberg (Canada)]

Kenvue Inc.  (KVUE) 
PDF In the all-cash deal, J&J will acquire NM26, a bispecific antibody that privately held Numab Therapeutics is preparing to put into mid-stage human studies, according to [Read more]